VA Salt Lake City Health Care System, 500 Foothill Dr, Salt Lake City, UT 84148, United States; Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, 30 N 1900 E, Salt Lake City, UT 84132, United States.
Clinical Epidemiology Program, Veterans Affairs Medical Center, 163 Veterans Dr, White River Junction, VT 05009, United States.
Vaccine. 2021 Jan 15;39(3):536-544. doi: 10.1016/j.vaccine.2020.12.016. Epub 2020 Dec 14.
Clostridioides difficile infection (CDI) is an important cause of diarrheal disease associated with increasing morbidity and mortality. Efforts to develop a preventive vaccine are ongoing. The goal of this study was to develop an algorithm to identify patients at high risk of CDI for enrollment in a vaccine efficacy trial.
We conducted a 2-stage retrospective study of patients aged ≥ 50 within the US Department of Veterans Affairs Health system between January 1, 2009 and December 31, 2013. Included patients had at least 1 visit in each of the 2 years prior to the study, with no CDI in the past year. We used multivariable logistic regression with elastic net regularization to identify predictors of CDI in months 2-12 (i.e., days 31 - 365) to allow time for antibodies to develop. Performance was measured using the positive predictive value (PPV) and the area under the curve (AUC).
Elements of the predictive algorithm included age, baseline comorbidity score, acute renal failure, recent infections or high-risk antibiotic use, hemodialysis in the last month, race, and measures of recent healthcare utilization. The final algorithm resulted in an AUC of 0.69 and a PPV of 3.4%.
We developed a predictive algorithm to identify a patient population with increased risk of CDI over the next 2-12 months. Our algorithm can be used prospectively with clinical and administrative data to facilitate the feasibility of conducting efficacy studies in a timely manner in an appropriate population.
艰难梭菌感染(CDI)是一种与发病率和死亡率不断上升相关的重要腹泻病病因。目前正在努力开发预防疫苗。本研究的目的是开发一种算法,以识别 CDI 高风险患者,从而纳入疫苗疗效试验。
我们对 2009 年 1 月 1 日至 2013 年 12 月 31 日期间美国退伍军人事务部医疗系统中年龄≥50 岁的患者进行了 2 阶段回顾性研究。纳入的患者在研究前 2 年中至少有 1 次就诊,且过去 1 年内无 CDI。我们使用多变量逻辑回归和弹性网络正则化来识别 2-12 个月(即第 31-365 天)期间 CDI 的预测因素,以允许抗体产生。使用阳性预测值(PPV)和曲线下面积(AUC)来衡量性能。
预测算法的要素包括年龄、基线合并症评分、急性肾衰竭、近期感染或高危抗生素使用、最近 1 个月的血液透析、种族以及近期医疗保健利用情况。最终算法的 AUC 为 0.69,PPV 为 3.4%。
我们开发了一种预测算法,以识别未来 2-12 个月内 CDI 风险增加的患者人群。我们的算法可以前瞻性地使用临床和行政数据,以便及时在合适的人群中开展疗效研究的可行性。